During this two-day Summit, attendees will examine an end-to-end REMS solution to help them comply with FDA safety requirements while ensuring patients have appropriate access to drugs and biologics. Industry professionals will convene to further the understanding of when REMS are required, the elements that need to be included in the REMS necessary for their product, as well as details needed for submission.
Top Reasons to Attend:
- Collaborate with industry leaders on innovative approaches for REMS design, implementations, solution updates and feedback from the FDA
- Comply with regulations pertaining to standardization and evaluations
- Assess REMS efficacy with proven and progressive methods
- Increase knowledge of upcoming REMS technologies, innovation, regulatory changes that will affect your work in risk management
- Discuss the hurdles of recent FDA guidance’s impacting REMS
- Lessen the burden on stakeholders with a comprehensive understanding of their nuanced needs and stressors
Speakers: Emily Freeman, Deb Tiffany
Time: 8:00 am to 4:00 pm
Early Bird Pricing — Register by December 21, 2018 — Pharmaceutical/Biotech/Medical Device Industry: USD 1895.0
Early Bird Pricing — Register by December 21, 2018 — Academic/Government: USD 1295.0
Standard Pricing — Pharmaceutical/Biotech/Medical Device Industry: USD 2095.0
Standard Pricing — Academic/Government: USD 1495.0
Onsite Pricing — Pharmaceutical/Biotech/Medical Device Industry: USD 2295.0
Onsite Pricing — Academic/Government: USD 1695.0
Find Bestrade reviews helpful? Start helping others by sharing your own experience:
11th Risk Evaluation and Mitigation Strategies S...
Reviews are public and modifiable.